The combined analgesic effect of gabapentin and transdermal fentanyl patch on acute and chronic pain after maxillary cancer surgeries

Journal of Maxillofacial and Oral Surgery

Volumn 8, Issue 1, 2009, Pages 55-59

  Dhasmana, Satish ^a   Singh, Vibha ^a   Pal, U S ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Gabapentin; Maxillary cancer; Transdermal fentanyl

Indexed keywords

EID: 84922129505     PISSN: 09728279     EISSN: 0974942X     Source Type: Journal    
DOI: 10.1007/s12663-009-0014-y     Document Type: Article

References (19)

1. Roy BC, Bahadur S, Thakar A (2002) Partial maxillectomy for malignant neoplasms of para nasal sinuses and hard palate. Indian J Cancer 39(3): 83–90
2. MacPherson RD (2000) The pharmacological basis of contemporary pain management. Pharmacol Ther 88(2): 163–185
3. Fassoulaki A, Triga A, Melemeni A, Sarantopoulos C (2005) Multimodal Analgesia with Gabapentin and Local Anesthetics Prevents Acute and Chronic Pain After Breast Surgery for Cancer. Anesth Analg 101(5): 1427–1432
4. Minville V, Lubrano V, Bounes V, Pianezza A, Rabinowitz A, Gris C, Samii K, Fourcade O (2008) Postoperative analgesia after total hip arthroplasty: patient-controlled analgesia versus transdermal fentanyl patch. J Clin Anesth 20(4): 280–283
5. Benítez-Rosario MA, Feria M, Salinas-Martín A, Martínez-Castillo LP, Martín-Ortega JJ (2004) Opioid Switching from Transdermal Fentanyl to Oral Methadone in Patients with Cancer Pain. Cancer 101(12): 2866–2873
6. Mercadante S, Porzio G, Ferrera P et al. (2008) Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. Eur J Pain 12(8): 1040–1046
7. Grond S, Radbruch L, Lehmann KA (2000) Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl. Clin Pharmacokinet 38(1): 59–89
8. Hanks GW, de Conno F, Cherny N et al. (2001) Morphine and alternative opioids in cancer pain. The EAPC recommendations. Br J Cancer 84(5): 587–593
9. Makin MK (2001) Strong opioids for cancer pain. J R Soc Med 94(1): 17–21
10. Ahmedzai S, Brooks D (1997) Transdermal fentanyl versus sustainedrelease oral morphine in cancer pain: preference, efficacy, and quality of life. TTS-Fentanyl Comparative Trial Group. J Pain Symptom Manage 13(5): 254–261
11. Wong JO, Chiu GL, Tsao CJ et al. (1997) Comparison of oral controlled release morphine with transdermal fentanyl in terminal cancer pain. Acta Anaesthesiol Sin 35(1): 25–32
12. Kongsgaard UE, Poulain P (1998) Transdermal fentanyl for pain control in adults with chronic cancer pain. Eur J Pain 2(1): 53–62
13. Mao J, Chen LL (2000) Gabapentin in pain management. Anesth Analg 91(3): 680–687
14. Cheng JK, Pan HL, Eisenach JC (2000) Antiallodynic effect of intrathecal gabapentin and its interaction with clonidine in a rat model of postoperative pain. Anesthesiology 92(4): 1126–1131
15. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L (1998) Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 280(21): 1837–1842
16. Sarantopoulos C, McCallum B, Kwok WM, Hogan Q (2002) Gabapentin decreases membrane calcium currents in injured as well as in control mammalian primary afferent neurons. Reg Anesth Pain Med 27(1): 47–57
17. Pan HL, Eisenach JC, Chen SR (1999) Gabapentin suppresses ectopic nerve discharges and reverses allodynia in neuropathic rats. J Pharmacol Exp Ther 288(3): 1026–1030
18. Kanai A, Sarantopoulos C, McCallum JB, Hogan Q (2004) Painful neuropathy alters the effect of gabapentin on sensory neuron excitability in rats. Acta Anaesthesiol Scand 48(4): 507–512
19. Patel MK, Gonzalez MI, Bramwell S, Pinnock RD, Lee K (2000) Gabapentin inhibits excitatory synaptic transmission in the hyperalgesic spinal cord. Br J Pharmacol 130(8): 1731–1734